Zong-zhe Z. Jiang

Luzhou, 646000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Coronary artery disease -related outcomes associated with semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis.

Coronary artery disease -related outcomes associated with semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: May 08, 2026

Correction: BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2.

Correction: BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2.

Journal: Cardiovascular diabetology

Published: May 08, 2026

Pan-PPAR agonists: emerging therapeutic strategies for metabolic dysfunction-associated steatotic liver disease.

Pan-PPAR agonists: emerging therapeutic strategies for metabolic dysfunction-associated steatotic liver disease.

Journal: Metabolism: clinical and experimental

Published: February 05, 2026

BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2.

BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2.

Journal: Cardiovascular diabetology

Published: October 03, 2024

The role of IL-1 family cytokines in diabetic cardiomyopathy.

The role of IL-1 family cytokines in diabetic cardiomyopathy.

Journal: Metabolism: clinical and experimental

Published: August 30, 2024

Proteomic and metabolomic profiling reveals the underlying molecular mechanisms in modified alternate-day fasting-mediated protection against Diabetic kidney disease.

Proteomic and metabolomic profiling reveals the underlying molecular mechanisms in modified alternate-day fasting-mediated protection against Diabetic kidney disease.

Journal: PloS one

Published: August 22, 2024

The effect of different dietary restriction on weight management and metabolic parameters in people with type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials.

The effect of different dietary restriction on weight management and metabolic parameters in people with type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials.

Journal: Diabetology & metabolic syndrome

Published: July 11, 2024

Targeting cell death in NAFLD: mechanisms and targeted therapies.

Targeting cell death in NAFLD: mechanisms and targeted therapies.

Journal: Cell death discovery

Published: April 18, 2024

Fecal virome transplantation: A promising strategy for the treatment of metabolic diseases.

Fecal virome transplantation: A promising strategy for the treatment of metabolic diseases.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 06, 2024

Annexin A1 binds PDZ and LIM domain 7 to inhibit adipogenesis and prevent obesity.

Annexin A1 binds PDZ and LIM domain 7 to inhibit adipogenesis and prevent obesity.

Journal: Signal transduction and targeted therapy

Published: January 10, 2024

The Role of Immune Cells in DKD: Mechanisms and Targeted Therapies.

The Role of Immune Cells in DKD: Mechanisms and Targeted Therapies.

Journal: Journal of inflammation research

Published: January 02, 2024

Based on network pharmacology and molecular docking to explore the molecular mechanism of Ginseng and Astragalus decoction against postmenopausal osteoporosis.

Based on network pharmacology and molecular docking to explore the molecular mechanism of Ginseng and Astragalus decoction against postmenopausal osteoporosis.

Journal: Medicine

Published: November 21, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026